已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study

医学 糖尿病 血脂异常 横断面研究 流行病学 内科学 血压 指南 血糖性 物理疗法 疾病 内分泌学 病理
作者
Xiaomei Zhang,Xingwu Ran,Zhangrong Xu,Zhifeng Cheng,Feixia Shen,Yanmei Yu,Lin Gao,Sanbo Chai,Changjiang Wang,Jianying Liu,Jing Liu,Zilin Sun,Jiajun Zhao,Linong Ji
出处
期刊:Journal of Diabetes and Its Complications [Elsevier BV]
卷期号:32 (2): 150-156 被引量:41
标识
DOI:10.1016/j.jdiacomp.2017.10.003
摘要

Abstract Aims To determine the epidemiological characteristics of lower extremity arterial disease (LEAD) in high-risk patients and identify practical gaps in LEAD management. Methods This cross-sectional study consecutively enrolled 10681 patients with type 2 diabetes from 30 hospitals across China from June 2016 to January 2017. All patients were assessed for LEAD by the Ankle-Brachial Index in conjunction with lower limb ultrasonography according to local guidelines. Results The mean age of patients was 64.2 years, and the median duration of diabetes was 9.0 years. The overall prevalence of LEAD was 21.2%, with 10.6% of patients diagnosed with LEAD before enrollment and 11.8% newly diagnosed at the present visit. Patients with older age, hypertension and dyslipidemia as well as those who smoked were at higher risk of developing LEAD. Only 55.0%, 28.2%, and 42.5% of participating patients reached the guideline-recommended goals for glycemic, blood pressure, and lipid control, respectively. Anti-hypertensive agents, lipid lowering therapies, anti-platelet agents, and vasodilators were underused, especially in newly diagnosed LEAD patients (44.1%, 46.2%, 35.3%, and 31.7%, respectively). Conclusions Despite the high prevalence of LEAD, it was still found to be underdiagnosed and undertreated in Chinese diabetes patients. More efforts should be directed at encouraging awareness of early LEAD and achieving guideline-recommended goals in type 2 diabetes patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
我是老大应助科研通管家采纳,获得10
1秒前
完美世界应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
午马未羊完成签到 ,获得积分10
1秒前
科研通AI5应助科研通管家采纳,获得10
1秒前
Ninico完成签到 ,获得积分10
6秒前
星星轨迹发布了新的文献求助10
6秒前
CHINA_C13发布了新的文献求助10
8秒前
12秒前
FashionBoy应助自由的厉采纳,获得10
13秒前
Capybara完成签到,获得积分20
19秒前
不倦应助小菡菡采纳,获得10
21秒前
火翟丰丰山心完成签到,获得积分10
22秒前
舒窈完成签到 ,获得积分10
26秒前
28秒前
34秒前
小蚊子发布了新的文献求助10
35秒前
dreamboat完成签到,获得积分10
37秒前
彭于晏应助KonanoDade采纳,获得10
38秒前
公交卡发布了新的文献求助10
39秒前
39秒前
科研通AI5应助嘉言懿行采纳,获得10
41秒前
开朗含海发布了新的文献求助10
43秒前
852应助Wsh采纳,获得30
45秒前
46秒前
CHINA_C13完成签到,获得积分20
50秒前
科研通AI5应助公交卡采纳,获得10
51秒前
兴奋采梦发布了新的文献求助10
52秒前
霜降完成签到 ,获得积分10
55秒前
如意的耳机完成签到 ,获得积分10
56秒前
瘦瘦牛排完成签到 ,获得积分10
57秒前
公交卡完成签到,获得积分10
1分钟前
momosci完成签到,获得积分10
1分钟前
小乖完成签到 ,获得积分10
1分钟前
Sam完成签到,获得积分10
1分钟前
FashionBoy应助海孩子采纳,获得10
1分钟前
1分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777504
求助须知:如何正确求助?哪些是违规求助? 3322864
关于积分的说明 10212146
捐赠科研通 3038215
什么是DOI,文献DOI怎么找? 1667229
邀请新用户注册赠送积分活动 798050
科研通“疑难数据库(出版商)”最低求助积分说明 758201